Categories: NewsNutrition

Theralogix Launches TheraCran(R) Max: Dual-Action Defense for Urinary Tract Health

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

ROCKVILLE, MD / ACCESSWIRE / January 7, 2025 / Theralogix, a trusted leader in the nutritional supplement industry, proudly announces the launch of TheraCran® Max, a premium dual-action supplement designed to deliver daily urinary tract health support.* By combining content-certified cranberry extract with pure d-mannose, TheraCran Max provides a comprehensive, broad-spectrum approach to urinary health.*

TheraCran Max utilizes two scientifically backed ingredients that work in complementary ways. Each daily serving contains 40 mg of soluble proanthocyanidins (PACs) from the juice portion of a whole cranberry extract plus 1,000 mg of d-mannose. Cranberry PACs and d-mannose work in unique ways, both binding to bacteria to help flush it from the urinary tract.*

TheraCran Max is the only cranberry and d-mannose supplement independently tested and certified by NSF® International, ensuring content accuracy, purity, and safety. This rigorous third-party certification sets TheraCran Max apart in a market where assurance of quality and content accuracy are essential, but often absent.

As with all Theralogix products, TheraCran Max is manufactured in the USA in a GMP-compliant facility, spotlighting the company’s commitment to high-quality, evidence-based supplements. It is dye-free, gluten-free, and formulated specifically for anyone seeking reliable urinary tract health support.*

Theralogix is the #1 urologist-recommended supplement brand. When it comes to premium, research-backed nutritional supplements, Theralogix has set the standard for over two decades. TheraCran Max is now available for purchase on Theralogix.com and Amazon.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Contact Information

Shannon Mahon
smahon@theralogix.com
301.464.7210

SOURCE: Theralogix

View the original press release on accesswire.com

Staff

Recent Posts

Altera Digital Health Makes Sunrise 25.1 Generally Available to Hospitals and Health Systems

Nearly 700 new features and enhancements to drive financial and clinical improvementsNIAGARA FALLS, N.Y.--(BUSINESS WIRE)--Altera…

2 hours ago

HeartBeam to Present at the iAccess Alpha Virtual Best Ideas Summer Conference on June 24, 2025

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac…

2 hours ago

Orthofix Announces Global Commercial Launch of the TrueLok Elevate Transverse Bone Transport System

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced the…

2 hours ago

Orthofix Announces Global Commercial Launch of the TrueLok Elevate Transverse Bone Transport System

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced the…

2 hours ago

Canadian Dental Hygienists Association (CDHA) Responds to Misinformation, Say Challenging Work Environments Must Be Addressed

Ottawa, Ontario--(Newsfile Corp. - June 17, 2025) - Thousands of dental hygienists across Canada are…

2 hours ago

Canadian Dental Hygienists Association (CDHA) Responds to Misinformation, Say Challenging Work Environments Must Be Addressed

Ottawa, Ontario--(Newsfile Corp. - June 17, 2025) - Thousands of dental hygienists across Canada are…

2 hours ago